Neurotech News — Free Preview
Recent brain-computer interface, neurostimulation and neuroimaging headlines from vetted sources, with a short preview of each story. Showing the 24 most recent of 437 tracked.
Latest news
- Medical EconomicsAug 5, 2026
BlueWind Medical Wins FDA Clearance for 15-Year Tibial Neuromodulation Implant
BlueWind Medical received FDA 510(k) clearance for Revi Extend, a next-generation version of its implantable tibial neuromodulation device for urgency urinary incontinence, extending the device's functional life from 10 to 15 years. The implant sits near…
Read the preview - en.ncsti.gov.cnJul 29, 2026
China's BCI Tech Steps Out of the Lab
A patient at Shanghai’s Huashan Hospital received the world’s first commercial implant of a regulator-approved invasive BCI on July 13 using Neuracle Technology’s NEO system, which decodes epidural signals to restore hand mobility via external devices. The…
Read the preview - PRNewswireJul 28, 2026
Aurenar Closes Oversubscribed $5.7M Seed Round for ICU Vagus Nerve Stimulation Platform
Aurenar, a St. 7 million seed round co-led by the American Heart Association's Go Red for Women Venture Fund and Solas BioVentures, with BJC Health and Kaleida Capital also participating.
Read the preview - www.globenewswire.comJul 28, 2026
Firefly Neuroscience (NASDAQ: AIFF) and Next Health Launch Precision Cognitive Health Initiative as FDA Advisory Committee’s Recommendation Backs Broader Access to Key Neuroprotective Peptides
Firefly Neuroscience and Next Health launched a precision cognitive health platform integrating Firefly’s FDA-cleared AI-powered EEG/ERP brain biomarker technology with personalized cognitive peptide protocols. The initiative follows an FDA Advisory…
Read the preview - BioSpaceJul 27, 2026
Neuvotion Launches First FDA-Cleared Product From Its Brain-Body Interface Platform
Neuvotion, founded by Chad Bouton to commercialize the research behind his Feinstein Institutes 'double neural bypass' work, announced its first FDA-cleared product: NeuStim, a non-invasive, AI-guided electrical muscle stimulation device for stroke and…
Read the preview - www.businesswire.comJul 27, 2026
Neuvotion Announces Commercialization of Brain-Computer Interface and Brain-Body Interface Technologies – Related Clinical Study Published in Nature Medicine
Neuvotion announced commercialization of its AI-guided neuromodulation and brain-computer interface technologies, including the FDA-cleared NeuStim wearable muscle stimulation system for post-stroke and spinal cord injury recovery. A concurrent Nature…
Read the preview - www.globenewswire.comJul 23, 2026
Precision Neuroscience™ Appoints John Donoghue, Pioneer of Brain–Computer Interfaces, as Scientific Advisor
, pioneer of the BrainGate BCI project and the first proof that a paralyzed person could control devices with thought, as Scientific Advisor. He will advise on device design, signal decoding, and clinical strategy for the Layer 7 cortical interface.
Read the preview - www.globenewswire.comJul 23, 2026
Autonomix Medical Secures New U.S. Patent Strengthening Next-Generation Precision Neuromodulation Platform
S. Patent No.
Read the preview - pharmaphorumJul 22, 2026
Precision Neuroscience Demonstrates Non-Invasive BCI Control Without Brain Implantation
Precision Neuroscience published video evidence that its investigational Layer 7 system — a thin electrode array placed on the brain's outer surface without penetrating brain tissue — let people control a computer, navigate a tablet, and play games using…
Read the preview - MassDeviceJul 22, 2026
ABILITY Neurotech Completes First-in-Human Procedure for Implantable Optical-Link BCI
Geneva-based ABILITY Neurotech carried out the first human procedure for its fully implantable, batteryless brain-computer interface at the Technical University of Munich's University Hospital Rechts der Isar, under investigators Arthur Wagner, Bernhard…
Read the preview - MobiHealthNewsJul 22, 2026
Science Corp Launches PRIMA Retinal Implant in Europe After CE Mark Approval
Science Corporation announced the commercial launch of PRIMA, a subretinal photovoltaic implant that restores functional central vision in patients with geographic atrophy from age-related macular degeneration, after receiving CE marking from DEKRA under…
Read the preview - www.businesswire.comJul 22, 2026
Science Corp. Announces European Commercial Launch of PRIMA, the Only Treatment to Restore Functional Central Vision to Patients with Geographic Atrophy Caused by Age-Related Macular Degeneration, a Leading Cause of Blindness
Science Corporation received CE mark under the EU Medical Device Regulation from DEKRA and launched commercial availability of its PRIMA subretinal photovoltaic BCI implant across 30 European countries. Clinical trials showed 80% of patients achieved…
Read the preview - www.morningstar.comJul 21, 2026
ABILITY Neurotech Announces First-In-Human Testing for Novel Brain-Computer Interface Technology
ABILITY Neurotech completed its first-in-human procedure for its implantable BCI technology during intra-operative recordings in brain-tumor patients at TUM University Hospital Rechts der Isar in Munich. The study validates neural signal acquisition in a…
Read the preview - www.globenewswire.comJul 20, 2026
Neuronetics Appoints Nir Naor Chief Financial Officer; Announces Additional Management Changes
Neuronetics appointed Nir Naor as Chief Financial Officer effective July 23, 2026. /Americas business.
Read the preview - BioSpaceJul 16, 2026Nature Medicine
Feinstein Institutes' 'Double Neural Bypass' Restores Movement and Touch in Complete Paralysis, Featured on Nature Medicine Cover
A three-year study led by Chad Bouton at the Feinstein Institutes for Medical Research, featured on the cover of Nature Medicine, showed that a hybrid brain-computer interface combining implanted electrodes with AI decoding and electrical stimulation of…
Read the preview - www.neurofounders.coJul 16, 2026
Fluent Raises $2M AUD to Advance Subscalp Speech BCI
Melbourne-based Fluent raised A$2 million in pre-seed funding to advance InScribe, a subscalp EEG speech brain-computer interface that sits under the skin above the skull and uses multimodal AI to decode attempted speech. The less-invasive approach targets…
Read the preview - www.medicaldevice-network.comJul 16, 2026
BIOTRONIK Neuro acquires Soin Neuroscience’s SCS IP portfolio
BIOTRONIK Neuro acquired a portfolio of intellectual property from Soin Neuroscience covering spinal cord stimulation waveform design, adaptive programming and machine-learning integration. The assets will support development of next-generation SCS systems…
Read the preview - www.businesswire.comJul 15, 2026
Hemispheric Emerges from Stealth with $52M in Funding to Launch Descartes, the First Frontier NeuroAI Model for Decoding the Human Brain
Israeli NeuroAI company Hemispheric emerged from six years of stealth with $52 million in early-stage funding to launch Descartes, a six-billion-parameter foundation model trained on more than 250,000 hours of multimodal EEG and behavioral data from over…
Read the preview - www.neurofounders.coJul 15, 2026
Neuralink Completes First Transdural Implant
Neuralink completed its first transdural N1 implant in a clinical trial participant, inserting electrode threads through the intact dura without a manual durotomy while retaining the craniotomy. The May 2026 procedure at Toronto Western Hospital, announced…
Read the preview - www.prnewswire.comJul 14, 2026
Newronika Receives CE Mark for αDBS®, Advancing Its Mission to Make Adaptive Therapy the Standard of Care
A. received CE Mark certification for its commercial αDBS adaptive deep brain stimulation system, the first such approval in the European Economic Area for a device that continuously senses local field potentials and automatically adjusts stimulation while…
Read the preview - BusinessWireJul 13, 2026
Cognito Therapeutics Presents AAIC 2026 Data Linking Spectris Neurostimulation to Lipid Transport Biomarkers in Alzheimer's
Cognito Therapeutics presented exploratory cerebrospinal fluid proteomics data at the Alzheimer's Association International Conference 2026, from its Phase 2 FLICKER study of the investigational Spectris sensory-stimulation platform in 10 amyloid-positive…
Read the preview - South China Morning PostJul 13, 2026
Neuracle Performs China's First Commercial Invasive Brain-Computer Interface Surgery
Surgeons at Huashan Hospital in Shanghai implanted Neuracle Medical Technology's NEO device in a patient with hand-mobility loss from a decade-old spinal cord injury, marking the first surgery performed under China's National Medical Products…
Read the preview - www.businesswire.comJul 13, 2026
Universal Brain Receives FDA 510(k) Clearance for Rapid Brain-Function Measurement Platform for Psychiatry
Universal Brain announced FDA 510(k) clearance for its UB ERP System, a dry-electrode EEG wearable with Neurotique ERP software that measures brain function via event-related potentials in under five minutes. The clearance advances objective,…
Read the preview - www.prnewswire.comJul 9, 2026
Theranica Announces Landmark Coverage Milestone as Nerivio® Exceeds Half of the U.S. Insured Population
S. states, exceeding half of the nation’s insured population.
Read the preview
The rest is inside NeurotechMag Pro
- Full AI summaries and “why it matters” analysis
- Filters, saved searches, alerts and CSV export
- Company profiles, investor lists and funding history